ETC
IART icon

Exchange Traded Concepts’s Integra LifeSciences IART Stock Holding History

Exchange Traded Concepts’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$740K Sell
41,230
-26,820
-39% -$375K ﹤0.01% 1027
2026
Q1 		$641K Buy
68,050
+17,077
+34% +$187K ﹤0.01% 961
2025
Q4 		$633K Buy
50,973
+13,760
+37% +$183K ﹤0.01% 966
2025
Q3 		$533K Sell
37,213
-2,322
-6% -$31.8K ﹤0.01% 997
2025
Q2 		$485K Buy
39,535
+14,456
+58% +$210K 0.01% 914
2025
Q1 		$551K Sell
25,079
-189
-0.7% -$4.44K 0.01% 775
2024
Q4 		$573K Sell
25,268
-8,135
-24% -$178K 0.01% 765
2024
Q3 		$607K Buy
33,403
+2,036
+6% +$47.2K 0.01% 724
2024
Q2 		$914K Buy
31,367
+1,591
+5% +$47.2K 0.02% 461
2024
Q1 		$1.06M Buy
29,776
+3,262
+12% +$130K 0.03% 426
2023
Q4 		$1.15M Sell
26,514
-3,307
-11% -$130K 0.03% 375
2023
Q3 		$1.14M Sell
29,821
-8,669
-23% -$365K 0.03% 362
2023
Q2 		$1.58M Buy
38,490
+10,549
+38% +$508K 0.04% 308
2023
Q1 		$1.6M Sell
27,941
-2,648
-9% -$149K 0.04% 242
2022
Q4 		$1.72M Sell
30,589
-4,531
-13% -$231K 0.05% 208
2022
Q3 		$1.49M Buy
35,120
+6,396
+22% +$328K 0.05% 184
2022
Q2 		$1.55M Sell
28,724
-4,216
-13% -$253K 0.05% 206
2022
Q1 		$2.12M Sell
32,940
-12,693
-28% -$836K 0.04% 220
2021
Q4 		$3.06M Sell
45,633
-1,676
-4% -$113K 0.06% 191
2021
Q3 		$3.24M Sell
47,309
-8,020
-14% -$567K 0.08% 165
2021
Q2 		$3.78M Buy
55,329
+3,823
+7% +$270K 0.12% 124
2021
Q1 		$3.56M Buy
51,506
+13,063
+34% +$885K 0.13% 109
2020
Q4 		$2.5M Buy
38,443
+16,392
+74% +$882K 0.12% 112
2020
Q3 		$1.04M Buy
22,051
+9,379
+74% +$446K 0.06% 162
2020
Q2 		$595K Buy
12,672
+9,452
+294% +$465K 0.1% 174
2020
Q1 		$144K Buy
3,220
+1,690
+110% +$88.7K 0.08% 226
2019
Q4 		$89K Buy
+1,530
New +$91.1K 0.02% 209

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Exchange Traded Concepts's IART Position: Q2 2026 in Review

Exchange Traded Concepts reduced its Integra LifeSciences (IART) stake by 39% in Q2 2026, selling an estimated $375K and leaving 41,230 shares worth $740K. The position accounts for ﹤0.01% of the portfolio, ranked #1027.

Exchange Traded Concepts first reported a position in IART in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.78M in Q2 2021. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Exchange Traded Concepts held 41,230 shares of Integra LifeSciences worth $740K as of Q2 2026.
  • Exchange Traded Concepts sold 26,820 Integra LifeSciences shares in Q2 2026, an estimated $375K.
  • Integra LifeSciences made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #1027 holding.
  • Exchange Traded Concepts first reported a position in Integra LifeSciences in Q4 2019 and has held it in 27 quarters since.
  • Exchange Traded Concepts's Integra LifeSciences position peaked at $3.78M in Q2 2021.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.